Last news
Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

Nona Biosciences and Visterra Partner to Advance Next-Generation Biotherapeutics for Immune-Mediated and Autoimmune Diseases

CAMBRIDGE, Mass., June 12, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreement with Visterra, Inc. to advance Visterra's...

Binance Users Can Now Personalize Their Experience with New AI-powered UI/UX

Binance Users Can Now Personalize Their Experience with New AI-powered UI/UX

91% of users rated the new UI/UX experience positively as Binance becomes the first major crypto exchange to move beyond a "one-size-fits-all" model by empowering users with smart widgets and a customizable homepage DUBAI, UAE, June 12, 2025...

Jianzhi Education Announces Plan to Implement ADS Ratio Change

Jianzhi Education Announces Plan to Implement ADS Ratio Change

BEIJING, June 12, 2025 /PRNewswire/ -- Jianzhi Education Technology Group Company Limited (the "Company" or "Jianzhi") (NASDAQ: JZ), a leading provider of digital educational content in China, today announced that it plans to change the ratio of its...

DayOne Signs Landmark CRESS Agreement with TNB to Secure Up to 500MW of Renewable Energy

DayOne Signs Landmark CRESS Agreement with TNB to Secure Up to 500MW of Renewable Energy

SINGAPORE and KUALA LUMPUR, Malaysia , June 12, 2025 /PRNewswire/ -- DayOne Data Centers, a global pioneer in digital infrastructure platforms, announced on June 11th the signing of a Corporate Renewable Energy Supply Scheme (CRESS) agreement with...

Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing

Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing

1st production of pharmaceutical grade egg and milk challenge meals Product portfolio of challenge meals now includes peanut, milk and egg Innovation pipeline includes development of 'Top 9' allergen products as well as a products suitable from 6...

Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025

Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025

Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL) post first-line therapy with a 24-month disease-free survival (DFS) rate of 74.2% DZD8586 exhibited significant antitumor...

HTX May Performance Report: Trading Volume Surges, Assets Grow Steadily, Rankings Rise Across 6 Major Data Platforms

HTX May Performance Report: Trading Volume Surges, Assets Grow Steadily, Rankings Rise Across 6 Major Data Platforms

SINGAPORE, June 12, 2025 /PRNewswire/ -- HTX, a leading global cryptocurrency exchange, has released its May Performance Report, highlighting its strategic growth and strengthened market presence amidst a volatile crypto market. Despite Bitcoin's...

Tuniu Announces Unaudited First Quarter 2025 Financial Results

Tuniu Announces Unaudited First Quarter 2025 Financial Results

NANJING, China, June 12, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the first quarter ended March 31, 2025....

1 ... 979 980 981 982 983 984 985 986 987 ... 3740
menu
menu